Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$82.00 | Shjfpm | Qsyqjnctdp |
Bio-Techne Reports Strong Growth and Improved Margin for Q3; Maintain $215 FVE
Narrow-moat Bio-Techne had a good fiscal third quarter that met our high expectations, reporting revenue growth of 25% and diluted EPS of $1.12, an increase of $0.20 over the previous year. We are maintaining our $215 fair value estimate.